News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.

1Bitget UEX Daily | Iran Denies Direct Talks; Oil Price Back Above $100; Nasdaq 100 Rule Change May Open Door for SpaceX (March 31, 2026)2Even a "ceasefire" does not mean "normalization," the world in 2026 will be more "stagflated" than expected3Iran Oil Waiver Releases 140 Million Barrels to Ease Price Pressure—Yet Boosts Iran’s Revenue, Heightening Risks for Market Balance
Flash
05:36
BeatSwap announces continuous growth in BTX token staking, now exceeding 6 million tokensBlockBeats news, on March 31, according to the latest official data from BeatSwap, over 6 million BTX have been staked. The current effective supply that can be fully traded and sold is approximately 3.06%, while the staking amount is equivalent to 13.2% of that circulating supply level. This indicates that, with a limited supply available for trading, market participation continues to rise. As BeatSwap's application scenarios continue to expand, on-chain staking participation is also growing steadily, showing that users' long-term confidence in and engagement with the ecosystem continues to strengthen.
05:35
Odaily Noon News1. Musk: Grok Imagine has achieved positive gross profit, video technology is key to AGI; 2. Nasdaq will remove the 10% free float threshold and introduce a fast-track index inclusion rule; 3. edgeX launched the EDGE airdrop query page, trading will open at 20:30 (UTC+8); 4. SBF accuses the judge of bias and claims the judge should recuse from his case; 5. Wang Chun: Sold a Thai apartment for 7 BTC; this property was previously purchased for 2,900 BTC; 6. A certain exchange established an internal “Next Bets” venture capital program to promote employee innovation projects; 7. NBA regular season: Hawks defeated Celtics, with an account making over 2.3 million USD in profit and more than 400,000 USD in a single game; 8. Bitcoin spot ETF saw a total net inflow of 69.4404 million USD yesterday, with ARKB leading at a net inflow of 33.0297 million USD.
05:25
Sanofi: Rezurock receives EU approval for the treatment of chronic graft-versus-host diseaseGlonghui, March 31|Sanofi announced that the drug Rezurock (Chinese common name: Belumosudil Mesylate Tablets) has received conditional marketing authorization from the European Commission for the treatment of chronic graft-versus-host disease in adults and children aged 12 and above, applicable in situations where other treatment options are limited in efficacy.
News